Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 1600 1632 1636 3774
This examiner grants 43% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18282644 | LTR TRANSPOSON COMPOSITIONS AND METHODS | Non-Final OA | Flagship Pioneering Innovations VI, LLC |
| 18649612 | CELL DISSOCIATION SOLUTION, CELL DISSOCIATION METHOD, AND CELL PRESERVATION METHOD | Non-Final OA | CANON KABUSHIKI KAISHA |
| 16428138 | Methods and Compositions for Treating Dystroglycanopathy Disorders | Final Rejection | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL |
| 18949619 | CELLS LACKING B2M SURFACE EXPRESSION AND METHODS FOR ALLOGENEIC ADMINISTRATION OF SUCH CELLS | Non-Final OA | President and Fellows of Harvard College |
| 17912690 | GENE THERAPY FOR COCKAYNE SYNDROME | Final Rejection | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. |
| 17722697 | TRANSGENIC SWINE, METHODS OF MAKING AND USES THEREOF, AND METHODS OF MAKING HUMAN IMMUNE SYSTEM MICE | Final Rejection | The Trustees of Columbia University in the City of New York |
| 19298798 | ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF MICRO-DYSTROPHIN TO TREAT MUSCULAR DYSTROPHY | Final Rejection | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL |
| 17783381 | TGFbeta1 Hyperactivation Causes Gender-Specific Calcific Aortic Stenosis | Non-Final OA | University of South Carolina |
| 17626903 | Genetically Modified Non-Human Animals and Methods of Use Thereof | Non-Final OA | YALE UNIVERSITY |
| 18164502 | CELLS AND METHODS OF USES AND MAKING THE SAME | Non-Final OA | Washington University |
| 18272430 | CHIMERIC TARGET FACTOR RECEPTOR | Non-Final OA | NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM |
| 16240472 | ADENO-ASSOCIATED VIRUS MEDIATED DELIVERY OF C1EI AS A THERAPY FOR ANGIOEDEMA | Final Rejection | Cornell University |
| 17753660 | COMPOSITIONS INCLUDING MOLECULES OF MODIFIED MRNA AND METHODS OF USING THE SAME | Final Rejection | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI |
| 18186856 | MRNA THERAPEUTIC COMPOSITIONS AND USE TO TREAT DISEASES AND DISORDERS | Non-Final OA | Translate Bio, Inc. |
| 17798796 | GENE THERAPY | Final Rejection | UCL BUSINESS LTD |
| 17767311 | HIGH FREQUENCY TARGETED ANIMAL TRANSGENESIS | Non-Final OA | The Jackson Laboratory |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy